KING STREET CAPITAL MANAGEMENT, L.P. - EUROPEAN BIOTECH ACQUTN CORP ownership

EUROPEAN BIOTECH ACQUTN CORP's ticker is EBACU and the CUSIP is G3167F110. A total of 38 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
KING STREET CAPITAL MANAGEMENT, L.P. ownership history of EUROPEAN BIOTECH ACQUTN CORP
ValueSharesWeighting
Q3 2021$496,000
-0.8%
50,0000.0%0.04%
+2.4%
Q2 2021$500,000
-0.6%
50,0000.0%0.04%
+7.9%
Q1 2021$503,00050,0000.04%
Other shareholders
EUROPEAN BIOTECH ACQUTN CORP shareholders Q2 2021
NameSharesValueWeighting ↓
Exos Asset Management LLC 50,000$502,0000.39%
Arena Capital Advisors, LLC- CA 300,000$3,020,0000.30%
MMCAP International Inc. SPC 250,000$2,516,0000.25%
PERISCOPE CAPITAL INC. 350,000$3,523,0000.14%
Kepos Capital LP 175,000$1,761,0000.11%
Ghisallo Capital Management LLC 150,000$1,508,0000.10%
Shaolin Capital Management LLC 200,000$2,013,0000.08%
Atalaya Capital Management LP 40,000$402,0000.08%
Radcliffe Capital Management, L.P. 200,000$2,013,0000.08%
GABELLI & Co INVESTMENT ADVISERS, INC. 57,789$581,0000.07%
View complete list of EUROPEAN BIOTECH ACQUTN CORP shareholders